Sponsor study identifier
observational
126
1 country
1
Study Start
June 2, 2016
Actual (reported)Primary Completion
December 31, 2016
Actual (reported)Study Completion
December 31, 2018
Actual (reported)The cerebral amyloïd angiopathy ( AAC) is a disease characterized by deposits of beta-amyloid peptids in the walls of the arteries of young and average calibre of the brain and the leptomeninx. The incidence of the AAC increases strongly with the age and represents a major cause of spontaneous brain haemorrhage to people over 60. The main demonstration is the lobar brain haemorrhage, the other ones are bleedings under arachnoid cortical and microbleedings leading to cognitive decline. Anatomical studies reported the presence of cortical infarcts in patients having amyloïd deposits suggesting an association between asymptomatic cortical cerebral infarcts and AAC. However prevalence and meaning of these infarcts in patients having an AAC remain badly known because of studies on low number of patients and the rarity of radiological analyses of these infarcts .A better knowledge of these asymptomatic cortical infarcts would allow to dread better cognitive disorders(confusions) presented by these patients, and to develop preventive strategies. Besides, the risk factors of severity of the AAC are little studied.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2, 2016
Actual (reported)December 31, 2016
Actual (reported)August 24, 2017
Actual (reported)August 25, 2017
Actual (reported)December 31, 2018
Actual (reported)number of patient with cerebral infarction and associated factors in a cohort of cerebral amyloid angiopathy patients
1day
investigators consult medical report concerning patient identified for cerebral amyloid angiopathy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Investigators select medical report of hospitalized patient between 2011/01/01 and 2015/12/31 in CAEN hospital and Paris St Joseph hospital ; these had an MRI for cerebral haemorrhage.
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
HODEL Jérome, Professor
GHPSJ
126 participants (actual enrollment reported by the registry).
First Submitted
August 24, 2017
First Posted
August 25, 2017
Study Start
June 2, 2016
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
December 31, 2016
Actual (reported)Study Completion
December 31, 2018
Actual (reported)Last Updated
February 4, 2019
Record last verified: 2018-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: